ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Jiande Han
Matched on ORCID iD 0000-0002-4465-7632; OpenAlex author ID A5101042526. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2024: 1 paper · 2025: 2 papers
Papers 3
- The Evolutionary Trajectory and Prognostic Value of GITR+ Tregs Reprogramed by Tumor-Intrinsic PD-1/c-MET Signaling in Pancreatic Cancer. Co-author DOI 10.1002/advs.202500806↗
- Intratumoral IL-33 + CD4 + FoxP3 + regulatory T cell infiltration determines poor clinical outcomes and intensive immunoevasive contexture in patients with pan… Co-author DOI 10.1097/js9.0000000000002733↗
- Poor clinical outcomes and immunoevasive contexture in CD161+CD8+ T cells barren human pancreatic cancer. Co-author DOI 10.1136/jitc-2023-008694↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ning Pu · 3 shared papers, 2024–2025 · strength 0.60
- Paper The Evolutionary Trajectory and Prognostic Value of GITR+ Tregs Reprogramed by Tumor-Intrinsic PD-1/c-MET Signaling in … DOI 10.1002/advs.202500806↗
- Paper Intratumoral IL-33 + CD4 + FoxP3 + regulatory T cell infiltration determines poor clinical outcomes and intensive immun… DOI 10.1097/js9.0000000000002733↗
- Paper Poor clinical outcomes and immunoevasive contexture in CD161+CD8+ T cells barren human pancreatic cancer. DOI 10.1136/jitc-2023-008694↗
- Hanlin Yin · 3 shared papers, 2024–2025 · strength 0.60
- Paper The Evolutionary Trajectory and Prognostic Value of GITR+ Tregs Reprogramed by Tumor-Intrinsic PD-1/c-MET Signaling in … DOI 10.1002/advs.202500806↗
- Paper Intratumoral IL-33 + CD4 + FoxP3 + regulatory T cell infiltration determines poor clinical outcomes and intensive immun… DOI 10.1097/js9.0000000000002733↗
- Paper Poor clinical outcomes and immunoevasive contexture in CD161+CD8+ T cells barren human pancreatic cancer. DOI 10.1136/jitc-2023-008694↗
- Qiangda Chen · 3 shared papers, 2024–2025 · strength 0.60
- Paper The Evolutionary Trajectory and Prognostic Value of GITR+ Tregs Reprogramed by Tumor-Intrinsic PD-1/c-MET Signaling in … DOI 10.1002/advs.202500806↗
- Paper Intratumoral IL-33 + CD4 + FoxP3 + regulatory T cell infiltration determines poor clinical outcomes and intensive immun… DOI 10.1097/js9.0000000000002733↗
- Paper Poor clinical outcomes and immunoevasive contexture in CD161+CD8+ T cells barren human pancreatic cancer. DOI 10.1136/jitc-2023-008694↗
- Taochen He · 3 shared papers, 2024–2025 · strength 0.60
- Paper The Evolutionary Trajectory and Prognostic Value of GITR+ Tregs Reprogramed by Tumor-Intrinsic PD-1/c-MET Signaling in … DOI 10.1002/advs.202500806↗
- Paper Intratumoral IL-33 + CD4 + FoxP3 + regulatory T cell infiltration determines poor clinical outcomes and intensive immun… DOI 10.1097/js9.0000000000002733↗
- Paper Poor clinical outcomes and immunoevasive contexture in CD161+CD8+ T cells barren human pancreatic cancer. DOI 10.1136/jitc-2023-008694↗
- Wenhui Lou · 3 shared papers, 2024–2025 · strength 0.60
- Paper The Evolutionary Trajectory and Prognostic Value of GITR+ Tregs Reprogramed by Tumor-Intrinsic PD-1/c-MET Signaling in … DOI 10.1002/advs.202500806↗
- Paper Intratumoral IL-33 + CD4 + FoxP3 + regulatory T cell infiltration determines poor clinical outcomes and intensive immun… DOI 10.1097/js9.0000000000002733↗
- Paper Poor clinical outcomes and immunoevasive contexture in CD161+CD8+ T cells barren human pancreatic cancer. DOI 10.1136/jitc-2023-008694↗
- Wenchuan Wu · 3 shared papers, 2024–2025 · strength 0.60
- Paper The Evolutionary Trajectory and Prognostic Value of GITR+ Tregs Reprogramed by Tumor-Intrinsic PD-1/c-MET Signaling in … DOI 10.1002/advs.202500806↗
- Paper Intratumoral IL-33 + CD4 + FoxP3 + regulatory T cell infiltration determines poor clinical outcomes and intensive immun… DOI 10.1097/js9.0000000000002733↗
- Paper Poor clinical outcomes and immunoevasive contexture in CD161+CD8+ T cells barren human pancreatic cancer. DOI 10.1136/jitc-2023-008694↗
- Zhihang Xu · 2 shared papers, 2025 · strength 0.41
- Paper The Evolutionary Trajectory and Prognostic Value of GITR+ Tregs Reprogramed by Tumor-Intrinsic PD-1/c-MET Signaling in … DOI 10.1002/advs.202500806↗
- Paper Intratumoral IL-33 + CD4 + FoxP3 + regulatory T cell infiltration determines poor clinical outcomes and intensive immun… DOI 10.1097/js9.0000000000002733↗
- Yaolin Xu · 2 shared papers, 2025 · strength 0.41
- Paper The Evolutionary Trajectory and Prognostic Value of GITR+ Tregs Reprogramed by Tumor-Intrinsic PD-1/c-MET Signaling in … DOI 10.1002/advs.202500806↗
- Paper Intratumoral IL-33 + CD4 + FoxP3 + regulatory T cell infiltration determines poor clinical outcomes and intensive immun… DOI 10.1097/js9.0000000000002733↗
- Haibo Wang · 2 shared papers, 2025 · strength 0.41
- Paper The Evolutionary Trajectory and Prognostic Value of GITR+ Tregs Reprogramed by Tumor-Intrinsic PD-1/c-MET Signaling in … DOI 10.1002/advs.202500806↗
- Paper Intratumoral IL-33 + CD4 + FoxP3 + regulatory T cell infiltration determines poor clinical outcomes and intensive immun… DOI 10.1097/js9.0000000000002733↗
- Jun Yu · 2 shared papers, 2025 · strength 0.41
- Paper The Evolutionary Trajectory and Prognostic Value of GITR+ Tregs Reprogramed by Tumor-Intrinsic PD-1/c-MET Signaling in … DOI 10.1002/advs.202500806↗
- Paper Intratumoral IL-33 + CD4 + FoxP3 + regulatory T cell infiltration determines poor clinical outcomes and intensive immun… DOI 10.1097/js9.0000000000002733↗
- Yun Jin · 2 shared papers, 2025 · strength 0.41
- Paper The Evolutionary Trajectory and Prognostic Value of GITR+ Tregs Reprogramed by Tumor-Intrinsic PD-1/c-MET Signaling in … DOI 10.1002/advs.202500806↗
- Paper Intratumoral IL-33 + CD4 + FoxP3 + regulatory T cell infiltration determines poor clinical outcomes and intensive immun… DOI 10.1097/js9.0000000000002733↗
- Liang Liu · 1 shared paper, 2025 · strength 0.20
- Yanfei An · 1 shared paper, 2025 · strength 0.20
- Wenquan Wang · 1 shared paper, 2025 · strength 0.20
- Weilin Mao · 1 shared paper, 2024 · strength 0.18
- Joseph R. Habib · 1 shared paper, 2024 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.